|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca Pharmaceuticals: |  | |
| Literature Review July-September 2008.
When a small molecule binds to a protein, it loses a significant amount of... | AstraZeneca Pharmaceuticals, CMOs Office, Alderley Park, Macclesfield, UK. | Pharm Stat. 2008 Nov 11.
DOI Direct Link |
| The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing.
The development of a novel series of imidazole pyrimidine amides as... | Cancer and Infection Research, AstraZeneca Pharmaceuticals, Alderley Park, | Bioorg Med Chem Lett. 2008 Oct 25.
DOI Direct Link |
| Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors.
The development of a novel series of imidazole pyrimidine amides as... | Cancer and Infection Research, AstraZeneca Pharmaceuticals, Alderley Park, | Bioorg Med Chem Lett. 2008 Oct 22.
DOI Direct Link |
| Adopting the CEO model--why physician executives should not be required to practice medicine.
B3LYP/6-31G* and CASMP2 calculations have been employed to study the ene... | AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA. | Physician Exec. 2008 Jul-Aug;34(4):24-6. |
| The role of histopathology in the identification of immunotoxicity.
Recently finalized regulatory guidance documents concerned with the... | Global Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, | J Immunotoxicol. 2005 Oct 1;2(4):181-3.
DOI Direct Link |